TSE:MFC

Manulife Financial (MFC.TO)

61.73
+0.50 (0.82%)
as of Aug 14, 2026, 8:00:00 pm Market Open.
1631 watching
0
Investor Insights
star iconAug 13, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC-T) has shown resilience and growth, particularly in Asia and wealth management, despite recent challenges such as a new tax on its products in Mainland China. The stock appears to be experiencing a phase of high expectations, as evidenced by its notable ranking among Canadian equities. While some experts express caution due to valuations approaching overbought territory, they also recognize MFC's solid fundamentals, including a healthy dividend yield and strong asset management. However, the stock has prompted mixed sentiments regarding its potential for further gains amidst a dynamic financial landscape, with some analysts suggesting it may be time to accumulate shares during a market pullback. Overall, the stock's performance is closely watched, with a general understanding that lower interest rates and strategic positioning may lead to a continued upward trajectory.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
DON'T BUY
Avoided all of the sub-prime catastrophes. Trading close to its fair market value
BUY
Solid operations and good growth prospects.
TOP PICK
Did a great deal with Hancock. Lots of capacity to buy from AIG. They will grow even further. Have a great Asian franchise.
TOP PICK
There is talk that they are looking at bits and pieces of AIG (AIG-N). This would be smart as there are some very profitable pieces internationally and in Canada. Have a depth of people throughout the company. Very reasonable multiple for a long-term holder.
BUY
Huge in the far east. First Canadian insurance company to get into China. Huge growth for them.
BUY
Likes its international diversification. The worry in the short term is the forthcoming change in CEO’s. Has a history of diversifying very well and growing outside of Canada and North America.
BUY
Great well run company. Missed the street on numbers but if you look at the components, they were actually quite good. A lot of great growth prospects in Asia.
HOLD
Canadian insurers sold off in light of the financial crisis but are still showing more solid characteristics than some of the US financials. Multiples have come down that it is now good value.
DON'T BUY
(Market Call Minute.) Great company. His concern is that when money starts moving back to the banks will it come out of the Lifecos.
DON'T BUY
Performance over the last little while has been less than stellar. Sees a flat line to slightly negative ahead. Doesn’t think market’s worries about insurance companies being the next place for financial problems is over. This company is pretty stable.
SELL
Banks have let go but the 2 major life insurance companies hung on. Sun Life has finally let go and this is the last of the companies that hasn't really set back to a level that he would be comfortable buying.
COMMENT
A superb company. Will continue to do well. Good marketing position in China and will be expanding that fairly rapidly. Good position in the US with John Hancock. Prefers Great West Lifeco (GWO-T) currently.
DON'T BUY
Sitting right on its support level and there is risk of it breaking down through it.
DON'T BUY
The whole of the financial sector is facing a big challenge going forward because of the subprime crisis in the US. Expect the company will do well over the next few years but can't see strong profit growth.
TOP PICK
When you can buy this under $40, it represents excellent value. One of the best managed and capitalized financial institutions in Canada. Sees them earning roughly $3 a share this year and about $3.30-$3.40 next year. ROE is the highest in the insurance group in between 16% and 18%.
Showing 1,711 to 1,725 of 2,284 entries